Improvement of Renal Function by Long-Term Sustained Eculizumab Treatment in a Patient with Paroxysmal Nocturnal Hemoglobinuria
Chronic kidney disease (CKD) is one of the major manifestations of paroxysmal nocturnal hemoglobinuria (PNH). CKD in PNH is induced mainly by intravascular hemolysis of PNH-affected red blood cells (RBC) missing the glycosylphosphatidylinositol-anchored proteins with complement-regulatory activities...
Saved in:
Main Authors: | Haruhiko Ninomiya, Naoshi Obara, Akiko Niiori-Onishi, Yasuhisa Yokoyama, Mamiko Sakata-Yanagimoto, Yuichi Hasegawa, Shigeru Chiba |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | Case Reports in Hematology |
Online Access: | http://dx.doi.org/10.1155/2015/673195 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Necrotizing Fasciitis in Paroxysmal Nocturnal Hemoglobinuria
by: Pusem Patir, et al.
Published: (2015-01-01) -
Eculizumab treatment for Chinese patients with hemolytic paroxysmal nocturnal hemoglobinuria (PNH): efficacy and safety – a single-center study
by: Leyu Wang, et al.
Published: (2025-12-01) -
Autosplenectomy in a Patient with Paroxysmal Nocturnal Hemoglobinuria (PNH)
by: Ethan Burns, et al.
Published: (2019-01-01) -
Diagnostic and Treatment Challenges of Paroxysmal Nocturnal Hemoglobinuria in Uganda
by: Boniface Amanee Elias Lumori, et al.
Published: (2019-01-01) -
Paroxysmal Nocturnal Hemoglobinuria: Diagnostic Challenges in Pediatric Patient
by: Dharshana Krishnaprasadh, et al.
Published: (2019-01-01)